Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review

Am J Ther. 2019 Sep/Oct;26(5):e653-e655. doi: 10.1097/MJT.0000000000000850.

Authors

Husnain Waseem¹, Carlos Henriquez Felipe¹, Arsalan Talib Hashmi¹, Maham Ansar², Asiya Batool², Angela Saverimuthu³, Stephan L Kamholz¹

Affiliations

¹ Department of Medicine, Maimonides Medical Center, Brooklyn, NY.
² Department of Medicine, Jinnah Hospital, Lahore, Pakistan.
³ Department of Hematology and Oncology, Maimonides Medical Center, Brooklyn, NY.

PMID: 30418222
DOI: 10.1097/MJT.0000000000000850

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antibiotics, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Cytarabine / administration & dosage
Cytarabine / adverse effects*
Drug Eruptions / diagnosis
Drug Eruptions / drug therapy
Drug Eruptions / etiology*
Ear
Exanthema / chemically induced*
Exanthema / diagnosis
Exanthema / drug therapy
Female
Glucocorticoids / therapeutic use
Humans
Leukemia, Myeloid, Acute / drug therapy*
Middle Aged
Remission Induction / methods
Scalp

Substances

Antibiotics, Antineoplastic
Antimetabolites, Antineoplastic
Glucocorticoids
Cytarabine